We are live on ! Find out more
GNPX icon

Genprex
GNPX

15 hedge funds and large institutions have $153K invested in Genprex in 2025 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 3 increasing their positions, 3 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

63% more capital invested

Capital invested by funds: $93.5K → $153K (+$59.4K)

33% more first-time investments, than exits

New positions opened: 4 | Existing positions closed: 3

7% more funds holding

Funds holding: 14 → 15 (+1)

0% less ownership

Funds ownership: 0% → 0% (-0%)

0% more repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 3

Holders
15
Holders Change
+1
Holders Change %
+7.14%
% of All Funds
0.2%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
3
Reduced
3
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$84.6K
2
UBS Group
UBS Group
Switzerland
+$24.4K
3
VF
Virtu Financial
New York
+$4.88K
4
FIM
Freedom Investment Management
Connecticut
+$4.58K
5
Citigroup
Citigroup
New York
+$3.36K

Top Sellers

Rank Fund Capital Flow
1
HighTower Advisors
HighTower Advisors
Illinois
-$18K
2
HF
HRT Financial
New York
-$11K
3
TSS
Two Sigma Securities
New York
-$5.5K
4
CCM
Corsair Capital Management
New York
-$2.45K
5
Geode Capital Management
Geode Capital Management
Massachusetts
-$2.44K
Name Holding Trade Value Shares
Change 		Change in
Stake
Susquehanna International Group
1
Susquehanna International Group
Pennsylvania
$69.4K +$84.6K +277 New
UBS Group
2
UBS Group
Switzerland
$29.9K +$24.4K +80 +205%
Geode Capital Management
3
Geode Capital Management
Massachusetts
$17.1K -$2.44K -8 -11%
VF
4
Virtu Financial
New York
$10K +$4.88K +16 +70%
TSS
5
Two Sigma Securities
New York
$4.91K -$5.5K -18 -47%
FIM
6
Freedom Investment Management
Connecticut
$3.78K +$4.58K +15 New
HIP
7
HUB Investment Partners
Texas
$3.53K +$611 +2 +17%
Vanguard Group
8
Vanguard Group
Pennsylvania
$3.49K – – –
HighTower Advisors
9
HighTower Advisors
Illinois
$3.19K -$18K -59 -82%
Citigroup
10
Citigroup
New York
$2.87K +$3.36K +11 New
BlackRock
11
BlackRock
New York
$2.16K – – –
TRCT
12
Tower Research Capital (TRC)
New York
$1.36K – – –
SS
13
SBI Securities
Japan
$552 – – –
Morgan Stanley
14
Morgan Stanley
New York
$218 – – –
Bank of America
15
Bank of America
North Carolina
$154 +$305 +1 New
HWM
16
HighMark Wealth Management
Minnesota
$114 – – –
NRG
17
Nemes Rush Group
Michigan
$57 – – –
AF
18
Allworth Financial
California
$29 – – –
Osaic Holdings
19
Osaic Holdings
Arizona
$23 – – –
MYIA
20
Mount Yale Investment Advisors
Colorado
$11 – – –
Fidelity Investments
21
Fidelity Investments
Massachusetts
$9 – – –
Group One Trading
22
Group One Trading
Illinois
$5 – – –
CW
23
Curio Wealth
Maryland
$2 – – –
GRP
24
Global Retirement Partners
California
$1 – – –
JP Morgan Chase
25
JP Morgan Chase
New York
$1 – – –
1
2

GNPX Hedge Fund Activity: Q2 2025 in Review

15 of the 7,603 institutional investors tracked by Wall St. Rank reported a position in Genprex (GNPX) for Q2 2025, worth a combined $153K — up 63% from $93.5K a quarter earlier.

Buyers outnumbered sellers: 4 funds opened new GNPX positions and 3 closed out — a net gain of 1 holder — while 3 added to existing stakes and 3 trimmed.

The largest buyer was Susquehanna International Group, opening a new position worth an estimated $84.6K. The largest seller was HighTower Advisors, cutting an estimated $18K.

  • 15 institutional investors held Genprex (GNPX) as of Q2 2025, up from 14 in Q1 2025.
  • Funds reported $153K of Genprex stock for Q2 2025, up 63% quarter-over-quarter.
  • 4 funds opened new Genprex positions in Q2 2025 and 3 closed out, a net change of +1 holder.
  • The largest Genprex buyer in Q2 2025 was Susquehanna International Group, an estimated $84.6K added.
  • The largest Genprex seller in Q2 2025 was HighTower Advisors, an estimated $18K sold.

Based on aggregated 13F filings for Q2 2025.